District 1199P Health & Welfare Plan v. Janssen, L.P.
784 F. Supp. 2d 508
D.N.J.2011Background
- Plaintiffs are District 1199P Health and Welfare Plan et al., third-party payors seeking recovery under RICO and state law for Risperdal marketing.
- Defendants Janssen L.P. and Johnson & Johnson allegedly promoted Risperdal for off-label uses through a comprehensive scheme.
- Plaintiffs claim they paid approximately 80% of Risperdal’s purchase price, prompted by allegedly fraudulent marketing.
- Risperdal is FDA-regulated; off-label uses include dementia-related, psychiatric, and behavioral conditions; 2006 FDA approval for autism.
- Plaintiffs seek to recover damages for overpayments and related costs caused by Defendants’ alleged misrepresentations and marketing practices.
- The Court grants Defendants’ Rule 12(b)(6) motion and dismisses Counts I-X of the Consolidated Complaint.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Plaintiffs adequately plead RICO injury. | Plaintiffs allege overpayment for Risperdal constitutes cognizable injury. | Defendants contend injury requires concrete harm beyond overpayment or safer alternatives. | Plaintiffs fail to plead cognizable RICO injury; dismissal warranted. |
| Whether the proximate cause requirement is satisfied. | Plaintiffs assert a direct chain from marketing to injury. | Causation is too indirect and involves intermediaries; reliance is not adequately pleaded. | Proximate causation not satisfied; no direct link shown. |
| Whether the enterprise element is adequately pled. | Plaintiffs identify Defendants and affiliated marketing network as an enterprise. | Enterprise pleading is insufficiently challenged; need more detail? | Enterprise element adequately pled; other elements fail. |
| Whether the RICO predicate acts (mail/wire fraud, bribery) are pled with Rule 9(b) specificity. | Plaintiffs detail letters, CME events, and publication strategies as predicate acts. | Pleading lacks 9(b) specificity linking acts to concrete injuries. | 9(b) requirements not met; predicate acts inadequately pled. |
| Whether NJCFA and related state claims survive causation and standing challenges. | NJCFA pleading suffices; TPPs may have standing as consumers. | Claims fail due to lack of proximate causation and standing; mislabeling of state claim. | NJCFA claim fails for lack of causation; Count V (Unfair/Deceptive) dismissed; other state claims dismissed. |
Key Cases Cited
- Sedima v. Imrex Co., 473 U.S. 479 (U.S. 1985) (foundation for RICO injury and proximate causation)
- Anza v. Ideal Steel Supply Corp., 547 U.S. 451 (U.S. 2006) (proximate causation central to RICO claims)
- Holmes v. SIPC, 503 U.S. 258 (U.S. 1992) (limits on causation and remedies in securities cases; proximate cause concept)
- Bridge v. Phoenix Bond & Indem. Co., 553 U.S. 639 (U.S. 2008) (proximate cause and damages considerations in RICO/related claims)
- Maio v. Aetna, Inc., 221 F.3d 472 (3d Cir. 2000) (injury requirement for RICO claims; cannot claim overpayment alone)
- In re Ins. Brokerage Antitrust Litig., 618 F.3d 300 (3d Cir. 2010) (applies RICO standards to insurance brokerage context)
- In re Warfarin Sodium Antitrust Litig., 391 F.3d 516 (3d Cir. 2004) (discusses cognizable injury in similar contexts)
- Turkette v. United States, 452 U.S. 576 (U.S. 1981) (enterprise concept under RICO)